Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Dietary fish oil containing omega 3 highly unsaturated fatty acids has cardioprotective and anti-inflammatory effects. Prostaglandins (PGs) and thromboxanes are produced in vivo both from the omega 6 fatty acid arachidonic acid (AA) and the omega 3 fatty acid eicosapentaenoic acid (EPA). Certain beneficial effects of fish oil may result from altered PG metabolism resulting from increases in the EPA/AA ratios of precursor phospholipids. Here we report in vitro specificities of prostanoid enzymes and receptors toward EPA-derived, 3-series versus AA-derived, 2-series prostanoid substrates and products. The largest difference was seen with PG endoperoxide H synthase (PGHS)-1. Under optimal conditions purified PGHS-1 oxygenates EPA with only 10% of the efficiency of AA, and EPA significantly inhibits AA oxygenation by PGHS-1. Two- to 3-fold higher activities or potencies with 2-series versus 3-series compounds were observed with PGHS-2, PGD synthases, microsomal PGE synthase-1 and EP1, EP2, EP3, and FP receptors. Our most surprising observation was that AA oxygenation by PGHS-2 is only modestly inhibited by EPA (i.e. PGHS-2 exhibits a marked preference for AA when EPA and AA are tested together). Also unexpectedly, TxA(3) is about equipotent to TxA(2) at the TP alpha receptor. Our biochemical data predict that increasing phospholipid EPA/AA ratios in cells would dampen prostanoid signaling with the largest effects being on PGHS-1 pathways involving PGD, PGE, and PGF. Production of 2-series prostanoids from AA by PGHS-2 would be expected to decrease in proportion to the compensatory decrease in the AA content of phospholipids that would result from increased incorporation of omega 3 fatty acids such as EPA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“EPA derived eicosanoids also display a reduced affinity for eicosanoid receptors rendering them up to 50%–80% less biologically active than AA derived eicosanoids [149].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [149]
In the citing paper
“Conversely, eicosanoids derived from n-3 PUFAs are considered to be less potent, reducing the intensity and duration of the inflammatory responses by immune cells [62].”
From Potential Roles of n-3 PUFAs during Skeletal Muscle Growth and Regeneration (2018) · cites this paper as [62]
Citations
Cites
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Self-citationThe Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Diversity of group types, regulation, and function of phospholipase A2.
Dennis, E. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36794-7 · Cited by 1,436
Biochemistry of Lipids, Lipoproteins and Membranes
(2021) · Elsevier eBooks · doi:10.1016/c2020-0-00089-7 · Cited by 1,400
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Self-citationSugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
Research works printed but not linked: 4
- Kris-Etherton, 2003, Arterioscler. Thromb. Vasc. Biol., 23, 20
- Fisher, 1989, Mol. Pharmacol., 35, 195
- Lands, 1973, Adv. Biosci., 9, 15
- Yu, 2005, J. Clin. Invest., 115, 986, 10.1172/JCI23683 · doi:10.1172/jci23683 · Paper page
Cited by
Items 101–200 of 404
Swardfager, W., Hennebelle, M., Yu, D., Hammock, B. D., LEVITT, A. J., Hashimoto, K., & Taha, A. Y. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.010 · Cited by 82
Asztalos, I. B., Gleason, J. A., Sever, S., Gedik, R., Asztalos, B. F., Horvath, K. V., Dansinger, M. L., Lamon‐Fava, S., & Schaefer, E. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.010 · Cited by 79
Dong, L., Zou, H.-C., Yuan, C., Hong, Y. H., Kuklev, D. V., & Smith, W. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698001 · Cited by 87
Self-citationFontes, J. D., Rahman, F., Lacey, S., Larson, M. G., Vasan, R. S., Benjamin, E. J., Harris, W. S., & Robins, S. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.043 · Cited by 81
“The administration of u-3 PUFAs also was associated with decreased production of potent pro-inflammatory autacoids derived from u-6 PUFAs [33,34].”
BackgroundLarson, M. K., Ashmore, J. H., Harris, K. A., Vogelaar, J. L., Pottala, J. V., Sprehe, M. R., & Harris, W. S. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-02-0084 · Cited by 71
“The diminished potency of TxA3 versus TxA2 has been questioned recently (30), however, and the extent to which the latter was produced in the current experiment during the P-OM3 periods is unknown.”
BackgroundEicosanoid pathway in colorectal cancer: Recent updates
Tunçer, S., & Banerjee, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11748 · Cited by 78
Bibus, D., & Lands, B. (2015) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.04.005 · Cited by 68
Sharma, N. P., Dong, L., Yuan, C., Noon, K. R., & Smith, W. L. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063115 · Cited by 68
“EPA and DHA are poorer substrates than AA for huPGHS-2 (Liu et al., 2006; Wada et al., 2007; Yuan et al., 2009).”
BackgroundResultSelf-citationHegde, S., Kaushal, N., Ravindra, K. C., Chiaro, C. R., Hafer, K. T., Gandhi, U. H., Thompson, J. T., van den Heuvel, J. P., Kennett, M. J., Hankey, P. A., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317750 · Cited by 69
Marine algae: A treasure trove of bioactive anti-inflammatory compounds
Ghallab, D. S., Ibrahim, R. S., Mohyeldin, M. M., & Shawky, E. M. (2024) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2023.116023 · Cited by 72
Tessaro, F. H. G., Ayala, T. S., & Martins, J. O. (2015) · BioMed Research International · doi:10.1155/2015/568408 · Cited by 70
A lipidomic perspective on inflammatory macrophage eicosanoid signaling
Norris, P. C., & Dennis, E. A. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.009 · Cited by 62
“These results are connected to the model of functional coupling (Murakami and Kudo, 2004), which suggests that PGIS activity is the prostaglandin synthase most tightly dependent on COX-2 metabolism.”
BackgroundInfluentialKumar, A. P. R., Mastana, S. S., & Lindley, M. R. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422415000116 · Cited by 70
“In an in vitro study by Wada et al.((99)) specificities of prostanoid”
BackgroundInfluentialSymposium review: Oxylipids and the regulation of bovine mammary inflammatory responses
Sordillo, L. M. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13855 · Cited by 65
“For example, n-3 PUFA are relatively poor substrates of COX compared with n-6 PUFA (Wada et al., 2007).”
BackgroundLund, I., Steenfeldt, S. J., Banta, G. T., & Hansen, B. W. (2008) · Aquaculture · doi:10.1016/j.aquaculture.2008.01.004 · Cited by 59
Molecular Mechanisms Linking Omega-3 Fatty Acids and the Gut–Brain Axis
Zinkow, A., Grodzicki, W., Czerwińska, M., & Dziendzikowska, K. (2024) · Molecules · doi:10.3390/molecules30010071 · Cited by 71
“An in vitro study on HEK293 cell lines demonstrated 50–80% lower activity of prostaglandin E3 (PGE3) compared to prostaglandin E2 (PGE2) on prostaglandin E2 receptors 1, 2, 3, and 4 (EP1, EP2, EP3, and EP4), indicating nuanced influence of dietary fats on neuroinflammatory responses [62].”
Investigating Substrate Promiscuity in Cyclooxygenase-2
Vecchio, A. J., Orlando, B. J., Nandagiri, R., & Malkowski, M. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372243 · Cited by 65
“glycerol (2-AG) and anandamide (AEA) (6-10).”
Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome
Maddipati, K. R., Romero, R. J., Chaiworapongsa, T., Chaemsaithong, P., Zhou, S.-L., Xu, Z., Tarca, A. L., Kusanovic, J. P., Gómez, R., Docheva, N., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p069096 · Cited by 59
“especially arachidonic acid, is also inhibited by their w-3 analogs (56, 57).”
BackgroundStupin, M., Kibel, A., Stupin, A., Selthofer-Relatić, K., Matić, A., Mihalj, M., Mihaljević, Z., Jukić, I., & Drenjančević, I. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01129 · Cited by 69
“The AA-derived prostaglandins and leukotrienes are potent pro-inflammatory mediators (Samuelsson et al., 1987), whereas the AA-derived metabolites lipoxins are potent antiinflammatory and pro-resolving molecules (Serhan, 1994; Wallace and Fiorucci, 2003; McMahon and Godson, 2004).”
BackgroundTracey, T. J., Kirk, S. E., Steyn, F. J., & Ngo, S. T. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.08.012 · Cited by 55
Engineering oilseeds to produce nutritional fatty acids
Damude, H. G., & Kinney, A. J. (2008) · Physiologia Plantarum · doi:10.1111/j.1399-3054.2007.00998.x · Cited by 55
Gut Microbial-Derived Metabolomics of Asthma
Lee‐Sarwar, K. A., Lasky-Su, J. A., Kelly, R. S., Litonjua, A. A., & Weiss, S. T. (2020) · Metabolites · doi:10.3390/metabo10030097 · Cited by 65
“Because omega-6 fatty acids give rise to inflammatory eicosanoids [22] and omega-3 fatty acids displace omega-6 fatty acids in cell membranes and give rise to anti-inflammatory pro-resolving mediators [23,24], a high omega-6 to omega-3 fatty acid ratio is thought to be pro-allergic.”
BackgroundDavinelli, S., Intrieri, M., Corbi, G., & Scapagnini, G. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1724871 · Cited by 59
“Despite this, several findings support the hypothesis that the balance between AA and EPA is important to regulate the synthesis of inflammatory mediators (Wada et al. 2007; Rizzo et al. 2010).”
BackgroundHales, D. B., Zhuge, Y., Lagman, J. A. J., Ansenberger, K., Mahon, C., Barua, A., Luborsky, J. L., & Bahr, J. M. (2008) · Endocrine · doi:10.1007/s12020-008-9080-z · Cited by 55
“Thus, it is likely that the contribution of each enzyme to prostaglandin production in the hen ovary is comparable [ 45 ].”
Yin, H., Brooks, J. D., Gao, L., Porter, N. A., & Morrow, J. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703108200 · Cited by 66
Endocannabinoids and Nutrition
Hansen, H. S., & Artmann, A. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01687.x · Cited by 64
Hibbeln, J. R., & Gow, R. V. (2014) · Military Medicine · doi:10.7205/milmed-d-14-00153 · Cited by 53
Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF
Hutchinson, A. J., Chou, C.-L., Israel, D. D., Xu, W., & Regan, J. W. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.01.018 · Cited by 57
“Activation of the EP3 receptor, which is expressed as multiple isoforms through alternative mRNA splicing, inhibits cyclic AMP signaling (Regan et al., 1994b) while also promoting the turnover of inositol phosphates (Wada et al. 2007).”
BackgroundSelf-citationNovel Eicosapentaenoic Acid-derived F3-isoprostanes as Biomarkers of Lipid Peroxidation
Song, W., Paschos, G. K., Fries, S., Reilly, M. P., Yu, Y., Rokach, J., Chang, C.-T., Patel, P., Lawson, J. A., & FitzGerald, G. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024075 · Cited by 52
Self-citationFurne, M., Holen, E., Araujo, P. W., Lie, K. K., & Moren, M. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2012.11.044 · Cited by 56
Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk
Murff, H. J., & Edwards, T. L. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0418-1 · Cited by 55
The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling
Fleming, I. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.03.001 · Cited by 57
“The products generated are a series of -3 prostaglandins [117,118] and leukotrienes [119] as well as the more recently identified unique family of fatty acid mediators referred to as protectins and resolvins that can be summarized together with the maresins as pro-resolving mediators [120,121].”
Dynamic interactions of n-3 and n-6 fatty acid nutrients
Lands, B., Bibus, D. M., & Stark, K. D. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.01.012 · Cited by 58
Prenatal oxidative balance and risk of asthma and allergic disease in adolescence
Sordillo, J. E., Rifas‐Shiman, S. L., Switkowski, K. M., Coull, B. A., Luttmann‐Gibson, H., Rice, M. B., Platts‐Mills, T. A. E., Kloog, I., Litonjua, A. A., Gold, D. R., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.07.044 · Cited by 56
“It is not clear to us why the protective associations for Vitamin D were found for upper airway and not lower airway outcomes in our study Long chain n-3 PUFAs may reduce allergic inflammation by displacing arachidonic acid in cell membranes, inducing a shift in eicosanoid pathways such that the mediators produced are…”
BackgroundPilkington, S. M., Rhodes, L. E., Al‐Aasswad, N. M. I., Massey, K. A., & Nicolaou, A. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300405 · Cited by 58
Dietary intake of PUFAs and colorectal polyp risk
Murff, H. J., Shrubsole, M. J., Cai, Q., Smalley, W. E., Dai, Q., Milne, G. L., Ness, R. M., & Zheng, W. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.024000 · Cited by 55
Human life: caught in the food web
Lands, W. E. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-89366-2_14 · Cited by 54
Wood, K., Lau, A., Mantzioris, E., Gibson, R. A., Ramsden, C. E., & Mühlhäusler, B. S. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.12.010 · Cited by 58
“Given that several bioactive 70 mediators derived from n-3 LCPUFA are less potent in their inflammatory actions than their 71 AA-derived analogs [10], and others actually have potent inflammation-resolving [11] or 72 neuroprotective properties [12], this competition has the potential to contribute to negative 73 healt…”
BackgroundSeegmiller, A. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916083 · Cited by 51
“EPA is a substrate for metabolism by cyclooxygenase to 3-series prostaglandins and by lipoxygenase to 5-series leukotrienes [49], pathways that are both increased in CF cells [39].”
BackgroundMaternal diet and its influence on the development of allergic disease
Miles, E. A., & Calder, P. C. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12453 · Cited by 56
Neuman, J. C., Schaid, M. D., Brill, A. L., Fenske, R. J., Kibbe, C. R., Fontaine, D. A., Sdao, S. M., Brar, H. K., Connors, K. M., Wienkes, H. N., et al. (2017) · Diabetes · doi:10.2337/db16-1362 · Cited by 49
“Previous binding and functional studies with a human EP3 receptor showed higher IC50 and lower relative affinity for PGE3 versus PGE2 (35,36).”
BackgroundErythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction
Park, Y., Lim, J., Lee, J., & Kim, S.-G. (2009) · British Journal of Nutrition · doi:10.1017/s0007114509990298 · Cited by 46
Omega-3 Fatty Acid Is a Potential Preventive Agent for Recurrent Colon Cancer
Vasudevan, A., Yu, Y., Banerjee, S., Woods, J., Farhana, L., Rajendra, S. G., Patel, A., Dyson, G. E., Levi, E., Maddipati, K. R., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0177 · Cited by 49
“poorer substrate to the metabolic enzymes compared with AA (36).”
BackgroundChristophersen, O. A., & Haug, A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-16 · Cited by 52
“Could geographical differences in micronutrient intake lead to geographical differences in the extent of ALA conversion into EPA and DHA, with this conversion being better in warm countries than in Canada and northern Europe?”
BackgroundInfluentialArm, J. P., Boyce, J. A., Wang, L., Chhay, H., Zahid, M. F., Patil, V., Govindarajulu, U. S., Ivester, P., Weaver, K. L., Sergeant, S., et al. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-141 · Cited by 49
“Briefly, cells were primed with 10 μg/L IL-3 on ice and stimulated with 0.01 to 1.0 μg/mL of 15A5, an activating monoclonal antibody to FcεRI, for 30 min at 37°C. Cysteinyl leukotrienes in the supernatant fluids were stored at −80°C until assayed by immunoassay (Cayman Chemical Company, Ann Arbor, MI or GE Healthcare)…”
BackgroundInfluentialEilati, E., Bahr, J. M., & Hales, D. B. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.05.018 · Cited by 51
Korbecki, J., Rębacz‐Maron, E., Kupnicka, P., Chlubek, D., & Baranowska‐Bosiacka, I. (2023) · Cancers · doi:10.3390/cancers15030946 · Cited by 47
“EPA C20:5n-3 reduces PGE2 production by COX-1 and, to a lesser extent, by COX-2 [135].”
BackgroundRamsden, C. E., Faurot, K. R., Carrera-Bastos, P., Cordain, L., De Lorgeril, M., & Sperling, L. S. (2009) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-009-0030-8 · Cited by 42
An eicosanoid-centric view of atherothrombotic risk factors
Gleim, S., Stitham, J., Tang, W. H., Martin, K. A., & Hwa, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0982-9 · Cited by 48
“However, the same study also highlights important limitations: namely, that TP activation remains nearly identical, and that PGHS-2 preferentially metabolizes AA series compounds [198].”
BackgroundBonafini, S., Antoniazzi, F., Maffeis, C., Minuz, P., & Fava, C. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.03.006 · Cited by 49
Hirakata, T., Lee, H., Ohba, M., Saeki, K., Okuno, T., Murakami, A., Matsuda, A., & Yokomizo, T. (2018) · The FASEB Journal · doi:10.1096/fj.201801805r · Cited by 49
Rasquel-Oliveira, F. S., da Silva, M. D. V., Martelossi-Cebinelli, G., Fattori, V., Casagrande, R., & Verri, W. A., Jr. (2023) · Molecules · doi:10.3390/molecules28135032 · Cited by 49
“COX-2 oxygenates EPA at about 45% the rate of AA [71], despite AA and EPA displaying Km values similar to those of COX-2, individually [72].”
ResultImmunometabolic role of long‐chain omega‐3 fatty acids in obesity‐induced inflammation
Flock, M. R., Rogers, C. J., Prabhu, K. S., & Kris‐Etherton, P. M. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2414 · Cited by 50
Novel regulatory roles of omega-3 fatty acids in metabolic pathways: a proteomics approach
Ahmed, A. A., Balogun, K. A., Bykova, N. V., & Cheema, S. K. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-6 · Cited by 49
“N-3 and n-6 PUFA form bioactive mediators which act on different receptors and proteins in the body [22].”
BackgroundOmega-3 PUFAs Lower the Propensity for Arachidonic Acid Cascade Overreactions
Lands, B. (2015) · BioMed Research International · doi:10.1155/2015/285135 · Cited by 38
“A productive view of the benefits from omega-3 (n-3) nutrients is that the dietary essential omega-6 (n-6) linoleic acid has a very narrow therapeutic window which is widened by n-3 nutrients.”
BackgroundChénais, B., & Blanckaert, V. D. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/712536 · Cited by 45
Maternal Nutritional Status and Development of Atopic Dermatitis in Their Offspring
Kang, C., Chiang, B., & Wang, L. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08780-y · Cited by 42
“The substitution of AA to EPA dampens the prostanoid signaling pathway, most significantly the PG endoperoxide H synthase-1, which is responsible for downstream products that finally convert into PGDs, PGEs, and PGFs [61].”
BackgroundYui, K., Imataka, G., Yohei, K., & Yamada, H. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.12.039 · Cited by 46
Bakr, R. B., Ghoneim, A. A., & Azouz, A. A. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102964 · Cited by 37
The structure of NS-398 bound to cyclooxygenase-2
Vecchio, A. J., & Malkowski, M. G. (2011) · Journal of Structural Biology · doi:10.1016/j.jsb.2011.07.019 · Cited by 45
“Additionally, while both COX-1 and COX-2 preferentially oxygenate AA, COX-2 has been shown to selectively utilize eicosapentaenoic acid and a wide spectrum of AA derivatives, such as the endocannabinoids 2-arachidonoyl glycerol and arachidonoyl ethanolamide as substrates (Kozak et al., 2000; Vecchio and Malkowski, 201…”
BackgroundDocosahexaenoic fatty acid (DHA) in the regulation of colon cell growth and cell death: A review
Skender, B., Vaculová, A. H., & Hofmanová, J. (2012) · Biomedical Papers · doi:10.5507/bp.2012.093 · Cited by 41
Cui, J., Shan, K., Yang, Q., Qi, Y., Qu, H., Li, J., Wang, R., Jia, L., Chen, W., Feng, N., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16570 · Cited by 40
Omega-3-fatty acids: Do they prevent cardiovascular disease?
Mason, R. P., Sherratt, S. C. R., & Eckel, R. H. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101681 · Cited by 44
Rund, K. M., Peng, S., Greite, R., Claaßen, C., Nolte, F., Oger, C., Galano, J., Balas, L., Durand, T., Chen, R., et al. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106386 · Cited by 36
“PGE3 possesses less affinity towards EP receptors and exhibits lower potency regarding second messenger release [78] and also have been shown to cause less secretion of pro-inflammatory IL-6 [79] compared to PGE2, this clear shift in the renal prostanoid pattern suggests that STD+n3 can contribute to a lower inflammat…”
BackgroundOmega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?
Brosolo, G., Porto, A. D., Marcante, S., Picci, A., Capilupi, F., Capilupi, P., Bertin, N., Vivarelli, C., Bulfone, L., Vacca, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119520 · Cited by 48
“lthough ALA is a ore ffi e s strate f r s t r s s elo ases, so e ex eri e tal e i e ce as e o strate a slo er e z atic eta olis of -3 P F s as co pared to -6 P F s [39].”
BackgroundKalantari, P., Narayan, V., Henderson, A. J., & Prabhu, K. N. (2009) · The FASEB Journal · doi:10.1096/fj.08-124982 · Cited by 36
Huang, C.-H., Hou, Y., Yeh, C., & Yeh, S. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.11.008 · Cited by 36
“n-3 PUFAs may alter eicosanoid formation, thus reducing inflammatory cytokine generation [6].”
BackgroundAsymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase
Arnold, W. R., Baylon, J. L., Tajkhorshid, E., & Das, A. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01037 · Cited by 38
Intravenous Lipid Emulsions to Deliver Bioactive Omega-3 Fatty Acids for Improved Patient Outcomes
Calder, P. C. (2019) · Marine Drugs · doi:10.3390/md17050274 · Cited by 36
“In this way, EPA and DHA are rather like the long-chain omega-6 (n-6) polyunsaturated fatty acid arachidonic acid (ARA, 20:4n-6), although the mediators produced from these three fatty acid substrates often have different biological activities or potencies [12,13].”
BackgroundProkopiou, E., Kolovos, P., Georgiou, C., Kalogerou, M., Potamiti, L., Sokratous, K., Kyriacou, K. C., & Georgiou, T. (2019) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000326 · Cited by 35
Polyunsaturated Fatty Acids: Immunomodulators in Older Adults
Hardin‐Fanning, F., Boissonneault, G. A., & Lennie, T. A. (2011) · Journal of Gerontological Nursing · doi:10.3928/00989134-20110201-01 · Cited by 34
Liu, Z., Huang, H., Xie, J., Xu, Y., & Xu, C. (2024) · Nature Communications · doi:10.1038/s41467-024-47960-8 · Cited by 36
“It has been reported that AA and n-3 PUFA directly compete with one another for metabolism and that theirmediators compete for receptors 43 .”
Aldoori, J., Cockbain, A. J., Toogood, G. J., & Hull, M. A. (2022) · Gut · doi:10.1136/gutjnl-2021-326362 · Cited by 35
Davinelli, S., Corbi, G., Righetti, S., Casiraghi, E., Chiappero, F., Martegani, S., Pina, R., Vivo, I. D., Simopoulos, A. P., & Scapagnini, G. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00487 · Cited by 36
“The interaction between AA and EPA is complex and still not properly understood, however, several findings support the hypothesis that the balance between AA and EPA is important to regulate the synthesis of inflammatory mediators and maintain cardiovascular health, especially during high-intensity exercise (Simopoulo…”
BackgroundKalogerou, M., Ioannou, S., Kolovos, P., Prokopiou, E., Potamiti, L., Kyriacou, K. C., Panayiotidis, M. I., Ioannou, M., Fella, E., Worth, E. P., et al. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108901 · Cited by 35
Burdge, G. C. (2022) · Lipids · doi:10.1002/lipd.12355 · Cited by 35
Lands, B., & Lamoreaux, E. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-46 · Cited by 31
Is essential fatty acid interconversion an important source of PUFA in humans?
Burdge, G. C. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114518003707 · Cited by 39
“Changes in the relative proportions of individual PUFA may modify cell function by changing the nature of lipid second messengers, including eicosanoids((2)), diacylglycerol and phosphatidic acid((3,4)).”
BackgroundMicrobiome Therapeutics: A Path Toward Sustainable Healthcare
Kumar, T., & Chauhan, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00010-3 · Cited by 29
Zarezadeh, R., Mehdizadeh, A., Leroy, J., Nouri, M., Fayezi, S., & Darabi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27101 · Cited by 32
Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates
Guthrie, G. J., & Burrin, D. G. (2021) · Nutrients · doi:10.3390/nu13020508 · Cited by 35
“Also, PGE3 has much lower affinity for some surface receptors leading to a weaker cellular response when there is a greater concentration of EPA-derived prostaglandins [116].”
BackgroundSkiba, G., Poławska, E., Sobol, M., Raj, S., & Weremko, D. (2014) · Archives of Animal Nutrition · doi:10.1080/1745039x.2014.992173 · Cited by 29
“Moreover, it is well known that the desaturation of FA is quantitatively modified by competition with FA incorporation in the lipids (e.g. Brenner 1974; Aro 2003; Harris et al. 2006; Wada et al. 2007).”
BackgroundInteraction between iron and omega-3 fatty acids metabolisms: where is the cross-link?
Ogłuszka, M., Lipiński, P., & Starzyński, R. R. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1862047 · Cited by 30
Possible Health Effects of a Wax Ester Rich Marine Oil
Schots, P. C., Pedersen, A. M., Eilertsen, K., Olsen, R. L., & Larsen, T. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00961 · Cited by 30
“These EPA-derived eicosanoids have been regarded less potent than those produced from AA, and thereby stimulate inflammation to a lesser extent (Goldman et al., 1983; Lee et al., 1984; Bagga et al., 2003; Wada et al., 2007; Tull et al., 2009).”
BackgroundSidorkiewicz, M. (2024) · Nutrients · doi:10.3390/nu16223937 · Cited by 32
“PUFAs are important components of cell membranes, and the changes in relative proportions of PUFAs can influence cell function by the modulation of the fluidity of membranes [19] and by alteration of lipid second messenger synthesis [20].”
Fish, n-3 fatty acids, cognition and dementia risk: not just a fishy tale
Saleh, R. N. M., & Minihane, A. M. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003700 · Cited by 34
“EPA produces less inflammatory PGs, TXAs (3-series) and LTs (5-series)((101)) relative to AA-derived oxylipins.”
BackgroundIwasaki, W., Kume, M., Kudo, K., Uchinami, H., Kikuchi, I., Nakagawa, Y., Yoshioka, M., & Yamamoto, Y. (2010) · Shock · doi:10.1097/shk.0b013e3181b2ffd2 · Cited by 27
“Once n-3 PUFA is incorporated into cellular membranes, it competes with n-6 PUFA and partially replaces or redistributes n-6 PUFA such as AA, resulting in reducing the precursors available for 2-series prostanoid production (8).”
BackgroundMusee, J., & Marnett, L. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381202 · Cited by 28
“Eicosapentaenoic acid is a poor substrate for oxygenation by PGHS-1, but its oxidation is stimulated by exogenous peroxide (26).”
BackgroundModifying Vegetable Oils for Food and Non-food Purposes
Cahoon, E. B., Clemente, T. E., Damude, H. G., & Kinney, A. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-77594-4_2 · Cited by 34
“…removed, has resulted in a substantial shift in the balance of ARA and EPA in the blood stream with numerous potential negative consequences (Hibbeln et al. 2004; Simopoulos 1999; Wada et al. 2007) including those disease states related to excessive inflammation or auto-immune conditions.”
BackgroundThe Mediterranean diet: Effects on proteins that mediate fatty acid metabolism in the colon
Djurić, Z. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00439.x · Cited by 33
“Phytochemicals, which have antioxidant properties, are plentiful in plant foods and would be expected to affect eicosanoids, since oxidative stress induces expression of COX-2.”
BackgroundInfluentialHaug, A., Nyquist, N. F., Mosti, T. J., Andersen, M., & Høstmark, A. T. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-104 · Cited by 30
“It has been found that purified COX-1 oxygenates EPA at a rate which is only 10% of the rate for AA, while EPA significantly inhibits AA oxygenation by COX-1 [24].”
BackgroundHaug, A., Olesen, I., & Christophersen, O. A. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-37 · Cited by 27
“In a recent study of the substrate specificities of enzymes and prostanoid receptors, it was found that COX-1 oxygenated EPA with only 10% of the efficiency of AA [8].”
BackgroundInfluentialOmega-3 Fatty Acids Supplementation: Therapeutic Potential in a Mouse Model of Stargardt Disease
Prokopiou, E., Kolovos, P., Kalogerou, M., Neokleous, A., Nicolaou, O., Sokratous, K., Kyriacou, K. C., & Georgiou, T. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23523 · Cited by 30
Opgenorth, J., Sordillo, L. M., Lock, A. L., Gandy, J. C., & VandeHaar, M. J. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-18045 · Cited by 32
Lands, B. (2014) · Military Medicine · doi:10.7205/milmed-d-14-00149 · Cited by 26
“A recent detailed report of the relative effectiveness of omega-3 and omega-6 structures in the processes that convert tissue HUFA to receptor-mediated responses described many examples in which omega-3 structures gave less intense actions than omega-6 structures.(15) Receptors in nearly every tissue of our body respo…”
BackgroundDu, Z., Ma, T., Winterthun, S., Kristiansen, K., Frøyland, L., & Madsen, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.002 · Cited by 26
Neilson, A. P., Ren, J., Hong, Y. H., Sen, A., Smith, W. L., Brenner, D. E., & Djurić, Z. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2012.630168 · Cited by 25
“In addition to altering arachidonic acid levels, the levels of the ω3 fatty acids EPA and DHA relative to arachidonic acid are critical for determining eicosanoid synthesis.”
BackgroundInfluentialSelf-citationExploring newer cardioprotective strategies: ω-3 fatty acids in perspective
Tremoli, E., Tufano, A., Russolillo, A., Lupoli, R., Minno, G. D., & Minno, M. N. D. D. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0008 · Cited by 31
“Although higher levels of DHA than of EPA are present in membrane phospholipids (60), data from JELIS challenge this formulation.”
BackgroundFrömel, T., & Fleming, I. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6150 · Cited by 25
Gose, T., Nakanishi, T., Kamo, S., Shimada, H., Otake, K., & Tamai, I. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.12.003 · Cited by 28
Metadata
- Authors
- Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., Smyth, E. M., Wilson, S. J., FitzGerald, G. A., Garavito, R. M., Sui, D. X., Regan, J. W., & Smith, W. L.
- Affiliations
- University of Michigan (US)
- Tokyo Medical and Dental University (JP)
- University of Pennsylvania (US)
- Michigan State University (US)
- University of Arizona (US)
- Corresponding author
- Smith, William L.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 31
- Pages
- 22254-22266
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047319374
- Cited by
- 400
- References
- 121
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 14 · 2021: 21 · 2020: 25 · 2019: 22 · 2018: 24 · 2017: 26 · 2016: 24 · 2015: 26 · 2014: 32 · 2013: 28 · 2012: 22
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32hl075993-01a1)
- National Heart, Lung, and Blood Institute (HL075993, HL56773, R01HL056773)
- National Institute of General Medical Sciences (GM-68848, R01GM068848)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- prostaglandins, eicosapentaenoic acid, arachidonic acid, omega-3 fatty acids, fish oil, prostanoid metabolism, cyclooxygenase-1, cyclooxygenase-2, prostaglandin D synthase, prostaglandin E receptors, prostaglandin F receptor, substrate specificity, EPA/AA ratio, phospholipid fatty acid composition
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Line, Fish Oils, Humans, Inositol Phosphates, Phospholipids, Prostaglandins, Thromboxane A2, Thromboxanes, Eicosapentaenoic Acid, Signal Transduction, Arachidonic Acid, Mice, Platelet-Rich Plasma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.